One of the highlights of this year’s American Society of Clinical Oncology (ASCO) meeting was the emerging treatment options in...
Read More...
The post Novel biologics are on the horizon for EGFR-mutated non-small cell lung cancer appeared first on Pharmaceutical Technology.